The Bioanalytical Challenges of In Vivo CAR-T Therapy Development
The concept of Chimeric antigen receptor T cell (CAR-T) therapy was first proposed in the late 1980s, and CAR design has continuously evolved in both...
« Return
Clinical Bioanalysis Strategy for Antibody Drug Conjugates (ADCs)
Related Posts
How to Address Metabolite Identification Challenges in Advanced Peptide Therapeutics
The success of GLP-1 drugs has driven a surge in advanced peptide therapeutic development and has transformed the treatment of metabolic disease. Engineered...